Response to intralesional steroid therapy (triamcinolone acetonide and
betamethasone acetate) was studied in 70 children of all ages with 74
cutaneous hemangiomas located in a variety of locations. One to seven
injections were given without anesthesia with a mean interval of 6 we
eks between the injections. Results analyzed 2 months after the last i
njection showed more than 75% reduction in volume in 43 (58.11%), 50%
to 75% reduction in 16 (21.62%), 25% to 50% reduction in 9 (12.16%), a
nd less than 25% reduction in 6 (8.11%) lesions. Response was not rela
ted to age, sex, or site of the lesion, but only 2 lesions (22.22%) wi
th an initial volume of more than 20 cm3 showed more than 50% reductio
n. None showed regrowth within a mean follow-up period of 14 months. T
ransient cushingoid faces and hypopigmentation were noted in 2 patient
s each. We feel that intralesional steroid therapy is safe and effecti
ve for all cutaneous hemangiomas irrespective of site, sex, or age of
the patient.